Paid Clinical Trials for Bipolar Disorder

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Bipolar Disorder

Top of Directory » All Categories » by Illness » Bipolar Disorder



  • Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

    Conditions:   Alcohol Dependence;   Bipolar Disorder;   Depression;   Mania;   Affective Psychosis
    Interventions:   Drug: Lamotrigine;   Drug: Placebo
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified November 2009
  • Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child

    Condition:   Bipolar Disorder
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified October 2009
  • Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

    Conditions:   Smoking Cessation;   Bipolar Disorder
    Interventions:   Drug: Varenicline (Chantix);   Drug: Placebo
    Sponsors:   University of Pittsburgh;   National Institute of Mental Health (NIMH);   Pfizer
    Not yet recruiting - verified November 2009
  • Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

    Condition:   Healthy
    Intervention:   Drug: Tolvaptan 15mg or 30mg or 60mg or Placebo
    Sponsor:   Korea Otsuka Pharmaceutical Co.,Ltd.
    Not yet recruiting - verified November 2009
  • Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis

    Conditions:   Psychosis;   Schizophrenia;   Bipolar Disorder;   Schizo-affective Disorder
    Intervention:   Other: Acceptance and Commitment Therapy
    Sponsors:   University of Glasgow;   Greater Glasgow and Clyde NHS
    Not yet recruiting - verified October 2009
  • Juvenile Bipolar Disorder Outpatient Program

    Conditions:   Bipolar Disorder;   Attention Deficit Disorder With Hyperactivity
    Intervention:   Drug: Psychopharmacotherapy
    Sponsors:   Federal University of Rio Grande do Sul;   Hospital de Clinicas de Porto Alegre
    Recruiting - verified October 2009
  • Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder

    Condition:   Bipolar Disorder
    Intervention:   Behavioral: Mindfulness-Based Cognitive Therapy
    Sponsor:   Douglas Mental Health University Institute
    Recruiting - verified November 2009
  • Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release

    Condition:   Bipolar Depression
    Interventions:   Drug: PF-04455242;   Drug: spiradoline;   Other: Placebo;   Drug: spiradoline
    Sponsor:   Pfizer
    Not yet recruiting - verified October 2009
  • Study in Adolescents With Schizophrenia or Bipolar Disorder

    Conditions:   Bipolar I Disorder;   Schizophrenia
    Interventions:   Drug: Olanzapine;   Behavioral: Standard behavioral weight intervention;   Behavioral: Intense behavioral weight intervention
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)

    Conditions:   Bipolar Disorder;   Depression
    Intervention:   Drug: PF-04455242
    Sponsor:   Pfizer
    Recruiting - verified October 2009
  • Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

    Condition:   Bipolar Depression
    Interventions:   Drug: quetiapine (Seroquel) XR;   Drug: quetiapine (Seroquel) XR;   Drug: placebo;   Drug: pramipexole dihydrochloride
    Sponsors:   Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.;   AstraZeneca
    Recruiting - verified October 2009
  • Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression

    Condition:   Acute Bipolar Depression
    Interventions:   Drug: Quetiapine fumarate XR;   Drug: Lithium carbonate
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009
  • Metabolic Abnormalities - OPT

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar I Disorder;   Metabolic Syndrome
    Interventions:   Drug: Aripiprazole;   Drug: Olanzapine;   Drug: Risperidone;   Drug: Quetiapine
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified July 2009
  • Quetiapine XR vs Sertraline in Acute Bipolar Depression as add-on Therapy

    Conditions:   Bipolar Disorder;   Bipolar Depression
    Interventions:   Drug: Quetiapine XR;   Drug: sertraline
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009
  • Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

    Condition:   Bipolar Depression
    Interventions:   Drug: cariprazine;   Drug: cariprazine;   Drug: placebo
    Sponsors:   Forest Laboratories;   Gedeon Richter Ltd.
    Recruiting - verified October 2009
  • A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

    Condition:   Bipolar Depression
    Interventions:   Drug: Olanzapine Fluoxetine Combination;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation

    Conditions:   Mood Disorder;   Mental Disorder Diagnosed in Childhood;   Attention Deficit and Disruptive Behavior Disorder;   Attention Deficit Hyperactivity Disorder
    Interventions:   Drug: Citalopram;   Drug: Methylphenidate
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified September 2009
  • Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolar 1 Acute Manic or Mixed Episode (Study 41044)(P05691)

    Condition:   Bipolar Disorder
    Interventions:   Drug: placebo;   Drug: risperidone;   Drug: asenapine
    Sponsor:   Schering-Plough
    Not yet recruiting - verified November 2009
  • Allopurinol Maintenance Study for Bipolar Disorder

    Conditions:   Bipolar Disorder;   Mania;   Mixed Mania
    Intervention:   Drug: Allopurinol
    Sponsors:   Cedars-Sinai Medical Center;   West Coast College of Biological Psychiatry
    Recruiting - verified November 2009
  • Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients

    Condition:   Bipolar Disorder
    Intervention:   Drug: lamictal
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

    Conditions:   Schizophrenia;   Bipolar
    Intervention:   Other: There is no intervention. This is an observational study model that is family based
    Sponsors:   University of Maryland;   National Institutes of Health (NIH)
    Recruiting - verified November 2009
  • Study to Evaluate the Efficacy and Safety of Aripiprazole in Combination With Lithium or Valproate Over 12 Weeks in the Treatment of Patients Diagnosed With Bipolar I Disorder Mania

    Condition:   Bipolar Disorder Mania
    Interventions:   Drug: Aripiprazole;   Drug: Placebo
    Sponsors:   Bristol-Myers Squibb;   Otsuka America Pharmaceutical
    Recruiting - verified August 2009
  • Treatment of Major Depressive Disorder (MDD) With Ziprasidone

    Condition:   Depression
    Interventions:   Drug: oral Ziprasidone;   Drug: Placebo and Ziprasidone;   Drug: Placebo
    Sponsors:   Cedars-Sinai Medical Center;   Pfizer
    Recruiting - verified November 2009
  • Allopurinol Add-on Treatment for Refractory Mania

    Conditions:   Bipolar Disorder;   Mixed Mania;   Treatment-Resistant Mania
    Interventions:   Drug: Allopurinol;   Drug: Placebo
    Sponsors:   Cedars-Sinai Medical Center;   National Alliance for Research on Schizophrenia and Depression
    Recruiting - verified November 2009
  • A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

    Conditions:   Psychotic Depression;   Major Depression With Psychotic Features;   Psychosis
    Interventions:   Drug: mifepristone;   Drug: placebo
    Sponsor:   Corcept Therapeutics
    Recruiting - verified November 2009
  • Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy

    Conditions:   Partial Meniscectomy;   Articular Cartilage Defect
    Interventions:   Device: Mechanical Shaver;   Device: Paragon T2
    Sponsor:   ArthroCare Corporation
    Recruiting - verified October 2009
  • Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance

    Conditions:   Insomnia;   Bipolar Disorder
    Interventions:   Drug: Ramelteon;   Drug: Placebo
    Sponsors:   Lindner Center of HOPE;   Takeda Global Research & Development Center, Inc.;   University of Cincinnati
    Recruiting - verified October 2009
  • A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder - Long-term Extension Of Study SCA104779 -

    Condition:   Bipolar Disorder
    Intervention:   Drug: BW430C (lamotrigine)
    Sponsor:   GlaxoSmithKline
    Recruiting - verified October 2009
  • Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Obesity;   Metabolic Syndrome
    Intervention:   Drug: olanzapine and melatonin
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   Eli Lilly and Company
    Recruiting - verified November 2009
  • Acamprosate vs. Placebo in Bipolar Alcoholics

    Conditions:   Alcohol Dependence;   Bipolar Disorder
    Interventions:   Drug: Acamprosate;   Drug: Placebo
    Sponsors:   Medical University of South Carolina;   Forest Laboratories
    Recruiting - verified November 2009
  • Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

    Condition:   Autism
    Interventions:   Dietary Supplement: Omega 3 fatty acids;   Other: Placebo
    Sponsors:   University of Medicine and Dentistry New Jersey;   National Center for Complementary and Alternative Medicine (NCCAM)
    Recruiting - verified October 2009
  • A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain

    Condition:   Weight Gain
    Interventions:   Drug: zonisamide;   Drug: olanzapine;   Drug: Zonisamide;   Drug: Sugar Pill (placebo)
    Sponsors:   Lindner Center of HOPE;   Eli Lilly and Company;   University of Cincinnati
    Recruiting - verified October 2009
  • Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

    Conditions:   Mood Disorders;   Healthy;   Unipolar Depression;   Bipolar Depression
    Intervention:   Drug: Transderm Scopolamine
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified September 2009
  • Brain Tissue Collection for Neuropathological Studies

    Conditions:   Bipolar Disorder;   Depression;   Anxiety Disorders;   Schizophrenia;   Tourette's Syndrome;   Brain Diseases
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified March 2009
    • Menu
    Find Paid Clinical Trials